4Pan CC,Chang YH,Chen KK,et al.Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence,progression,and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder:a clinicopathologic study of 1,515 cases[J].Am J Clin Pathol,2010;133(5):788-95.
5Alkhateeb SS,Neill M,Bar-Moshe S,et al.Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Ba-cille Calmette-Guerin[J].Urol Ann,2011;3(3):119-26.
6Lammers RJ,Witjes JA.Developments in intravesical therapy for non-muscle-invasive bladder cancer[J].Expert Rev Anticancer Ther,2010;10(12):1903-16.
7Sylvester RJ,Oosterlinck W.An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer:has the evidence changed[J]?Eur Urol,2009;56(1):43-5.
8Inoue K,Kuno T,Fukuhara H,et al.Clinical experience with transure-thral resection of bladder tumor(TUR-Bt)guided by photodynamic diag-nosis(PDD)[J].Nihon Hinyokika Gakkai Zasshi,2009;100(7):661-70.
9Koritsiadis G,Tyritzis SI,Koutalellis G,et al.The effect of alpha-blocker treatment on bladder hypoxia inducible factor-1alpha regulation during lower urinary tract obstruction[J].Int Braz J Urol,2010;36(1):86-94.
10Geavlete B,Jecu M,Multescu R,et al.TURis plasma vaporization in non-muscle invasive bladder cancer-the first Romanian experience with a new technique[J].J Med Life,2010;3(1):100-5.
